Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
810.00    -40.00 (-4.71%)
Bid:
810.00
Ask:
816.00
Spread: 6.00 (0.741%)
Market Cap: £373.38m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM/Interim Management Statement

13 Apr 2010 07:00

RNS Number : 0520K
Porvair PLC
13 April 2010
Β 

ο»Ώ

FOR IMMEDIATE RELEASE

13 April 2010

Β 

Porvair plc

AGM Statement and Interim Management Statement

Β 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group will today, 13Β April 2010, make the following Interim Management Statement at its Annual General Meeting:

Β 

Porvair has made an encouraging start to the 2010 financial year. In the four months to 31 March 2010, profit before tax is well ahead of the prior year. Current net borrowings are Β£3.3m lower than the equivalent time last year. At constant exchange rates, revenues are around 5% higher than the prior period, with recovery or continued growth in most markets offset by expected modest declines in aerospace filtration sales.

Β 

In the Metals Filtration division sales revenues are 13% higher than the prior period. This business has a lower cost base following its 2009 restructuring and as a result profitability is better. It should be noted that whilst levels of demand in 2010 have improved, they remain below those of 2004-2008 and management continue to look at projects that will boost the underlying performance of this division. Key to this will be the sustained success of new products, which continue to go well. 85% of the division's aluminium customers have now converted to the patented Selee CS-Xβ„’ filter. Upgrades have been introduced in recent weeks that further enhance this market leading product in the aluminium industry. In the iron foundry industry, a similarly exciting new product, the patented Selee ICβ„’ filter, has now been adopted by several leading automotive and agricultural machinery manufacturers in the US.

Β 

In the Microfiltration division sales revenues are slightly ahead of the prior year. Seal Analytical has made a strong start with improved sales in the US and Europe and continuing strength in Asia helped by the introduction of the Seal Analytical AQ1β„’ water analyser in February 2010. The division is seeing satisfactory levels of demand in energy and nuclear filtration where several larger orders are scheduled for delivery later in the year. Growth in this division's US industrial filtration business has been robust. This is offset by a decline in aerospace schedules compared with a strong opening quarter of the prior year. Aerospace sales in 2010 are at similar levels to the second half of 2009 with run rates and order schedules showing modest improvements over the last three months.

Β 

The Company will be announcing its interim results for the six months ending 31 May 2010 on Tuesday 29 June 2010.

Β 

For further information, please contact:

Β 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

Β 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSSFLFLEFSSEDL
Date   Source Headline
7th Apr 20094:45 pmRNSResult of AGM
7th Apr 20097:00 amRNSAGM/Interim Management Stmt
20th Mar 20095:30 pmRNSHolding(s) in Company
16th Feb 20093:27 pmRNSHolding(s) in Company
3rd Feb 20093:31 pmRNSHolding(s) in Company
3rd Feb 20093:13 pmRNSHolding(s) in Company
2nd Feb 20094:40 pmRNSHolding(s) in Company
2nd Feb 20094:29 pmRNSHolding(s) in Company
27th Jan 20097:00 amRNSPreliminary Results
21st Jan 200910:50 amRNSHolding(s) in Company
10th Dec 20087:00 amRNSTrading update
2nd Dec 20082:54 pmRNSHolding(s) in Company
17th Oct 20087:00 amRNSInterim Management Statement
1st Sep 200812:00 pmRNSTotal Voting Rights
15th Aug 20086:29 pmRNSHolding(s) in Company
15th Aug 20086:15 pmRNSHolding(s) in Company
31st Jul 20084:14 pmRNSIssue of Equity
30th Jul 200812:24 pmRNSHolding(s) in Company
9th Jul 20087:00 amRNSAcquisition of Seal
1st Jul 20083:49 pmRNSHolding(s) in Company
24th Jun 20087:00 amRNSInterim Results
4th Jun 20087:00 amRNSTrading Statement
23rd May 20083:35 pmRNSHolding(s) in Company
19th May 20084:15 pmRNSDirector/PDMR Shareholding
19th May 200812:17 pmRNSDirector/PDMR Shareholding
29th Apr 20084:36 pmRNSHolding(s) in Company
9th Apr 20084:00 pmRNSResult of AGM
9th Apr 20087:00 amRNSAGM/Interim Management Stmt
1st Apr 20087:00 amRNSAcquisition
31st Mar 20088:00 amRNSTotal Voting Rights
26th Mar 20081:00 pmRNSAnnual Information Update
19th Mar 20087:00 amRNSBlocklisting Interim Review
11th Mar 20083:20 pmRNSFiling of Documents
5th Mar 20087:01 amRNSContract Wins
27th Feb 20087:01 amRNSParticipation in EU Project
29th Jan 20087:05 amRNSRe Agreement
29th Jan 20087:00 amRNSPreliminary Results
19th Dec 20074:46 pmRNSHolding(s) in Company
10th Dec 200711:56 amRNSHolding(s) in Company
10th Dec 20077:00 amRNSTrading Statement
2nd Oct 200711:35 amRNSLease of larger factory
2nd Oct 200711:27 amRNSDirectorate Change
2nd Oct 20078:44 amRNSDirector/PDMR Shareholding
31st Jul 20079:32 amRNSTotal Voting Rights
30th Jul 200711:00 amRNSDirector/PDMR Shareholding
26th Jun 20077:02 amRNSInterim Results
15th Jun 20078:00 amRNSAdditional Listing
6th Jun 20077:00 amRNSTrading Update
5th Jun 200711:28 amRNSAnnual Information Update
31st May 20071:10 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.